Globalworld globe
United Kingdom
North America
Europe
  • facebook
  • linkedin
Medical Developments International
  • Home
  • Products
    • Asthma & COPD
    • Penthrox
    • Medical Devices
    • Veterinary
  • About
    • Distributor Information
    • Careers
    • Associations
  • Investors/Media
    • Financial Reports
    • Board of Directors/Management
    • Corporate Governance
    • Media Centre
    • Diversity Policy
    • Share Trading Policy
  • Healthcare Professionals
  • Contact

Archives

Author Archives: kingharez
Sep 5, 2014AaronNews

ASX Announcement: Supply Agreement for Respiratory Products in the UK

Medical Developments International (MVP) is delighted to advise it has entered into an exclusive agreement with PSUK to supply its range of respiratory devices in the UK. The agreement includes minimum quantities for the next 3 years that will drive ongoing sales growth of MVP respiratory devices in the UK. PSUK’s parent company, Phoenix Healthcare […]

Read more
Jul 9, 2014AaronNews

Trial conducted to evaluate newer methods of pain relief for limb injuries

SINGAPORE: A year-long trial is being conducted on two medications to ensure patients get a faster and more effective delivery of pain relief. The Singapore General Hospital (SGH) and Singapore Civil Defence Force (SCDF) will study the suitability of Penthrox and Tramadol for early pain relief. Penthrox is delivered through an inhaler while Tramadol is […]

Read more
May 29, 2014AaronNews

ASX Announcement: Overseas Registration and Partnership Update

Update on European Marketing Application In November 2013, Medical Developments International (MVP) submitted its regulatory dossier and Marketing Authorisation Application for review to ‘The Medicines and Healthcare Products Regulatory Agency’ (MHRA) in England. On 27 January, 2014 MVP received its first round of questions from the MHRA. We have completed our responses and we are […]

Read more
Jun 10, 2013AaronNews

CSIRO Successful completion of first milestone

In August 2012 MVP announced it had entered into a research and development program with the CSIRO designed to introduce a new, more efficient, significantly lower manufacturing cost process for the pharmaceutical compound used in Penthrox®. We are delighted to announce the first milestone, which is to manufacture commercial grade methoxyflurane in much larger quantities […]

Read more
Feb 25, 2013AaronNews

Chairman’s and CEO’s Report

Download CEO’s & Chairman’s Report as PDF RECORD PROFIT STRONG GROWTH AND 3 CENTS FULLY FRANKED INTERIM DIVIDEND Medical Developments International Ltd. (ASX:MVP) delivered a Record Net Profit After Tax of $1,444,000 for the half year ended 31 December 2012, which represents a 25% increase on H1FY2012 ($1,156,000). The financial result represents: 23% increase in […]

Read more
Jan 2, 2013AaronNews

ASX Announcement

27 December 2012 ASX ANNOUNCEMENT Significant Developments and Opportunities in Asthma Devices Consistent with MVP’s strategy of broadening the availability and use of its core products, MVP makes the following announcement about positive developments in its asthma range of products. UPDATE ON AUSTRALIA On 31 October MVP announced the winning of a competitive tender and […]

Read more
May 11, 2012AaronNews

MEDICAL DEVELOPMENTS EXPANDS INTO EUROPE

Medical Developments is pleased to announce it has established a UK subsidiary company and appointed a European Business Development Manager based in London. Initially our European Business Development Manager will capitalize on the sale of MVP’s range of Medical Device’s and in particular our leading range of Asthma Devices. This follows the recent successful signing […]

Read more

Contact Us

for information on our range of products

Find a distributor

in our global network

Investors

invest in a company with
innovative foresight

News

  • Green Whistle gets the Green Light – FDA clears US Penthrox clinical trial

    2 March 2022 ASX ANNOUNCE...

  • MVP FY22 Half Year Results Investor Presentation

    25 February 2022 ASX anno...

  • MVP FY22 Half Year Report and Accounts

    24 February 2022 ASX Anno...

Healthcare Professional Registration

Login to access healthcare professional resources



Remember Me

Forgot password? | Register

Medical Developments International

Address:
4 Caribbean Drive, Scoresby,
Victoria, 3179
Australia
Phone: +61 3 9547 1888
Email: [email protected]
ABN: 14 106 340 667
For Medical Enquiries:

Phone: 1800 PENTHROX (1800 736 847)
Email: [email protected]

Email Newsletter